Search research articles
Contact Us
Filters
Showing results (411-420 of 535) with videos related to
Page
of 54
Sort By:
Clinical Chemistry
|
October 16, 2010
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus
Søren S Lund, Martin Petersen, Merete Frandsen, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Lamivudine is not effective in primary Sjögren's syndrome
B Gescuk, A J Wu, J P Whitcher, et al.
Sports Health
|
September 29, 2022
Risk Factors for Athletic Pubalgia in Collegiate Football Student-Athletes: A Retrospective Cohort Study
Alexander J Neuville, Clint L Benge, Vehniah K Tjong, et al.
Biochimica Et Biophysica Acta
|
December 19, 1986
Effects of cholesterol and lipoproteins on endocytosis by a monocyte-like cell line
M Esfahani, L Scerbo, S Lund-Katz, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
|
April 1, 1985
Phenotypic and genotypic characterization of penicillinase-producing strains of Neisseria gonorrhoeae
E S Falk, D Danielsson, B Bjorvatn, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes
Ralph A DeFronzo, Ele Ferrannini, Guntram Schernthaner, et al.
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie
|
September 12, 2012
Influence of model specifications on the reliabilities of genomic prediction in a Swedish-Finnish red breed cattle population
E Rius-Vilarrasa, R F Brøndum, I Strandén, et al.
Atherosclerosis
|
August 7, 1998
Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
M C Phillips, K L Gillotte, M P Haynes, et al.
Cardiovascular Diabetology
|
January 31, 2015
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study
Rimei Nishimura, Yuko Tanaka, Kazuki Koiwai, et al.
CJC Open
|
July 19, 2024
Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial
Ayodele Odutayo, Bernard Zinman, Christoph Wanner, et al.
Page
of 54
Search research articles
Search
Showing results (411-420 of 535) with videos related to
Sort By:
Page
of 54
Clinical Chemistry
|
October 16, 2010
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus
Søren S Lund, Martin Petersen, Merete Frandsen, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Lamivudine is not effective in primary Sjögren's syndrome
B Gescuk, A J Wu, J P Whitcher, et al.
Sports Health
|
September 29, 2022
Risk Factors for Athletic Pubalgia in Collegiate Football Student-Athletes: A Retrospective Cohort Study
Alexander J Neuville, Clint L Benge, Vehniah K Tjong, et al.
Biochimica Et Biophysica Acta
|
December 19, 1986
Effects of cholesterol and lipoproteins on endocytosis by a monocyte-like cell line
M Esfahani, L Scerbo, S Lund-Katz, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
|
April 1, 1985
Phenotypic and genotypic characterization of penicillinase-producing strains of Neisseria gonorrhoeae
E S Falk, D Danielsson, B Bjorvatn, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes
Ralph A DeFronzo, Ele Ferrannini, Guntram Schernthaner, et al.
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie
|
September 12, 2012
Influence of model specifications on the reliabilities of genomic prediction in a Swedish-Finnish red breed cattle population
E Rius-Vilarrasa, R F Brøndum, I Strandén, et al.
Atherosclerosis
|
August 7, 1998
Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
M C Phillips, K L Gillotte, M P Haynes, et al.
Cardiovascular Diabetology
|
January 31, 2015
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study
Rimei Nishimura, Yuko Tanaka, Kazuki Koiwai, et al.
CJC Open
|
July 19, 2024
Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial
Ayodele Odutayo, Bernard Zinman, Christoph Wanner, et al.
Page
of 54